Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIOMET for PCOS in Adolescent Girls and Young Women
NCT05394142Phase 2Recruiting
- Sponsor
- Fundació Sant Joan de Déu
- Start
- May 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of spironolactone, pioglitazone, metformin in polycystic ovary syndrome (PCOS), sponsored by Fundació Sant Joan de Déu. Started May 2022; status: recruiting.
02
Drugs
spironolactonepioglitazonemetformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05394142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05394142.